In time for the recent celebration of World Hepatitis Day on July 28, biopharmaceutical company Gilead Sciences, Inc. officially announced the launch of its 2021 Gilead Asia Pacific ALL4LIVER Grant, a new grant supporting local communities in strengthening liver disease education and awareness efforts across Asia Pacific.
The biennial grant aims to support the World Health Organization's 2030 goal of eliminating global viral hepatitis. As Hepatitis B and C affect 325 million people worldwide, and Asia continuously carrying the burden of these diseases with 178 million infections, Gilead's 2021 grant program banners the theme "Empowerment Through Education," supporting community-led projects to help improve people's liver health in the region.
Applications for the 2021 ALL4LIVER Grant are now open until October 31, 2021 to non-governmental or advocacy organizations and community groups in 11 countries in Asia Pacific: Singapore, Hong Kong, India, Malaysia, Pakistan, Philippines, South Korea, Taiwan, Thailand, and Vietnam.
This year's version of the grant seeks to support projects in hepatitis B with a focus on strengthening peer support, improving awareness and health literacy, and developing digital platforms or innovative tools for education.
The grant program aims to empower organizations and help bring liver health education and viral hepatitis information to the forefront of public health initiatives to address the unmet needs in the region. ALL4LIVER is inspired by a regional study conducted by Gilead, which found critical gaps in the public awareness and attitudes towards viral hepatitis.
"Liver health, particularly viral hepatitis, remains a public health threat affecting millions of people across the Asia Pacific region. Awareness of chronic hepatitis B and actions that can be taken to improve health remain low in many communities most impacted by the disease. Through this new grant program, we look forward to supporting innovative projects that can propel regional efforts to make viral hepatitis elimination a reality," said Alex Kalomparis, Vice President of Public Affairs, International at Gilead Sciences.
Interested non-governmental or advocacy organizations and community groups can find out more about their eligibility to apply for the Asia Pacific 2021 ALL4LIVER Grant at www.gileadall4liver.com. Applications are open until 11:59 PM (GMT +8) of October 31, 2021.
Image credit: Andrea Piacquadio from Pexels